$43.60
0.160.37%
Last update: 9:30 AM
15 minutes delayed
Comments
Loading...
Cerevel Therapeutics Hldg
CERENASDAQ
Latest news for Cerevel Therapeutics Hldg (NASDAQ:CERE) Stock
Cerevel Therapeutics Hldg Stock (NASDAQ: CERE)
Categories: All
Wednesday, July 03, 2024
Thursday, June 27, 2024
Tuesday, June 25, 2024
Tuesday, June 04, 2024
Thursday, April 18, 2024
Monday, March 25, 2024
Friday, February 16, 2024
Tuesday, February 06, 2024
Friday, February 02, 2024
Monday, January 29, 2024
Monday, January 08, 2024
Friday, December 29, 2023
Thursday, December 28, 2023
Friday, December 22, 2023
Monday, December 11, 2023
Friday, December 08, 2023
Thursday, December 07, 2023
- AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
- HC Wainwright & Co. Downgrades Cerevel Therap...
- Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Why Cerevel Therapeutics Stock Is Higher
- Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
- Cerevel Therapeutics shares are trading highe...
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Thursday
- Where Cerevel Therapeutics Hldg Stands With Analysts
- Piper Sandler Downgrades Cerevel Therapeutics...
- Cantor Fitzgerald Downgrades Cerevel Therapeu...
Wednesday, December 06, 2023
- Why Cerevel Therapeutics Holdings Is Moving After-Hours
- AbbVie Expects Proposed Cerevel Transaction T...
- Cerevel Therapeutics shares are trading highe...
- AbbVie To Acquire Cerevel Therapeutics; Trans...
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- AbbVie Nears Roughly $8B For Drug Developer C...